明德生物
(002932)
| 流通市值：31.00亿 | | | 总市值：46.18亿 |
| 流通股本：1.56亿 | | | 总股本：2.33亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 494,486,276.36 | 778,450,496.23 | 985,872,470.91 | 1,015,682,930.54 |
| 结算备付金 | 0 | - | - | 0 |
| 拆出资金 | 0 | - | - | 0 |
| 衍生金融资产 | 0 | - | - | 0 |
| 应收票据及应收账款 | 902,012,394.53 | 990,729,494.56 | 1,064,792,638.08 | 1,210,240,968.98 |
| 其中：应收票据 | 0 | 572,860.8 | 572,860.8 | 891,423.77 |
| 应收账款 | 902,012,394.53 | 990,156,633.76 | 1,064,219,777.28 | 1,209,349,545.21 |
| 应收款项融资 | 0 | - | - | 43,539,173.2 |
| 预付款项 | 80,902,727 | 85,746,381.02 | 50,376,691.52 | 45,492,875.02 |
| 应收保费 | 0 | - | - | 0 |
| 应收分保账款 | 0 | - | - | 0 |
| 应收分保合同准备金 | 0 | - | - | 0 |
| 其他应收款合计 | 9,378,957.97 | 10,268,575.19 | 10,185,606.02 | 9,333,771.69 |
| 其中:应收利息 | 0 | - | - | 0 |
| 应收股利 | 0 | - | - | 0 |
| 买入返售金融资产 | 0 | - | - | 0 |
| 存货 | 120,512,276.15 | 123,502,007.66 | 125,427,522.25 | 128,768,749.66 |
| 合同资产 | 0 | - | - | 0 |
| 一年内到期的非流动资产 | 320,511,875 | 204,990,972.22 | - | 0 |
| 其他流动资产 | 129,849,776.3 | 127,140,642.71 | 172,346,406.85 | 174,276,853.29 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,120,880,457.63 | 2,384,054,743.91 | 2,531,590,450.34 | 2,749,924,437.09 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | - | - | 0 |
| 债权投资 | 0 | - | - | 0 |
| 其他债权投资 | 0 | - | - | 0 |
| 长期应收款 | 0 | - | - | 0 |
| 长期股权投资 | 145,456,069.38 | 145,456,069.39 | 151,008,333.76 | 146,358,333.76 |
| 其他权益工具投资 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 其他非流动金融资产 | 0 | - | - | 0 |
| 投资性房地产 | 0 | - | - | 0 |
| 固定资产 | 298,032,831.63 | 309,797,015.23 | 322,378,812.24 | 335,034,366.12 |
| 在建工程 | 447,115,145.95 | 280,200,385.92 | 240,315,232.98 | 185,185,423.27 |
| 生产性生物资产 | 0 | - | - | 0 |
| 油气资产 | 0 | - | - | 0 |
| 使用权资产 | 21,904,432.67 | 22,399,496.42 | 23,197,626.73 | 23,378,956.57 |
| 无形资产 | 16,936,213.59 | 17,147,669.26 | 17,369,220.82 | 17,698,664.49 |
| 开发支出 | 0 | - | - | 0 |
| 商誉 | 0 | - | - | 0 |
| 长期待摊费用 | 12,910,136.92 | 12,746,870.9 | 13,777,546.25 | 14,865,843.26 |
| 递延所得税资产 | 204,332,910.84 | 209,431,974.49 | 210,355,465.17 | 210,177,002.23 |
| 其他非流动资产 | 3,552,372,983.81 | 3,542,187,778.51 | 3,720,845,417.41 | 3,693,976,867.41 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,709,060,724.79 | 4,549,367,260.12 | 4,709,247,655.36 | 4,636,675,457.11 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 6,829,941,182.42 | 6,933,422,004.03 | 7,240,838,105.7 | 7,386,599,894.2 |
| 流动负债: | | | | |
| 短期借款 | 3,000,000 | 3,000,000 | 3,000,000 | 23,614,136.5 |
| 向中央银行借款 | 0 | - | - | 0 |
| 吸收存款及同业存放 | 0 | - | - | 0 |
| 拆入资金 | 0 | - | - | 0 |
| 交易性金融负债 | 0 | - | - | 0 |
| 衍生金融负债 | 0 | - | - | 0 |
| 应付票据及应付账款 | 409,435,487.94 | 493,311,071.46 | 599,093,810.94 | 681,578,620.12 |
| 其中：应付票据 | 20,742,916.65 | 20,742,916.65 | - | 0 |
| 应付账款 | 388,692,571.29 | 472,568,154.81 | 599,093,810.94 | 681,578,620.12 |
| 预收款项 | 0 | - | - | 0 |
| 合同负债 | 40,586,997.18 | 43,460,999.23 | 40,033,174.21 | 53,168,153.76 |
| 卖出回购金融资产款 | 0 | - | - | 0 |
| 应付手续费及佣金 | 0 | - | - | 0 |
| 应付职工薪酬 | 106,121,783.84 | 107,950,498.86 | 118,841,679.5 | 153,719,040.08 |
| 应交税费 | 10,633,453.42 | 13,360,814.03 | 10,026,504.98 | 20,169,138.19 |
| 其他应付款合计 | 65,477,088.68 | 59,638,434.06 | 75,005,938.23 | 75,548,762.92 |
| 其中:应付利息 | 0 | - | - | 0 |
| 应付股利 | 0 | - | - | 0 |
| 应付分保账款 | 0 | - | - | 0 |
| 保险合同准备金 | 0 | - | - | 0 |
| 代理买卖证券款 | 0 | - | - | 0 |
| 代理承销证券款 | 0 | - | - | 0 |
| 一年内到期的非流动负债 | 8,155,867.48 | 8,155,867.48 | 8,155,867.48 | 7,289,052.93 |
| 其他流动负债 | 1,761,232.22 | 1,982,161 | 4,034,391.36 | 4,275,432.14 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 645,171,910.76 | 730,859,846.12 | 858,191,366.7 | 1,019,362,336.64 |
| 非流动负债: | | | | |
| 长期借款 | 0 | - | - | 0 |
| 应付债券 | 0 | - | - | 0 |
| 优先股 | 0 | - | - | 0 |
| 永续债 | 0 | - | - | 0 |
| 租赁负债 | 16,692,328.68 | 16,969,263.61 | 17,807,133.36 | 18,252,680.8 |
| 长期应付款 | 0 | - | - | 0 |
| 长期应付职工薪酬 | 0 | - | - | 0 |
| 预计负债 | 3,848,640.25 | 3,033,517.6 | 3,033,517.6 | 3,033,517.6 |
| 递延收益 | 14,260,000 | 14,260,000 | 14,260,000 | 14,260,000 |
| 递延所得税负债 | 39,646,145.82 | 39,646,145.82 | 39,646,145.82 | 39,589,895.79 |
| 其他非流动负债 | 0 | - | - | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 74,447,114.75 | 73,908,927.03 | 74,746,796.78 | 75,136,094.19 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 719,619,025.51 | 804,768,773.15 | 932,938,163.48 | 1,094,498,430.83 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 232,520,957 | 232,520,957 | 232,520,957 | 232,520,957 |
| 其他权益工具 | 0 | - | - | 0 |
| 优先股 | 0 | - | - | 0 |
| 永续债 | 0 | - | - | 0 |
| 资本公积 | 817,891,388.45 | 817,891,388.45 | 820,178,006.63 | 820,178,006.63 |
| 减:库存股 | 182,108,715.49 | 162,874,596 | 9,944,017.79 | 0 |
| 其他综合收益 | 0 | - | - | 0 |
| 专项储备 | 0 | - | - | 0 |
| 盈余公积 | 615,047,764.7 | 615,047,764.7 | 615,047,764.7 | 615,047,764.7 |
| 一般风险准备 | 0 | - | - | 0 |
| 未分配利润 | 4,405,096,938.51 | 4,396,010,336.09 | 4,387,700,645.1 | 4,358,142,933.67 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,888,448,333.17 | 5,898,595,850.24 | 6,045,503,355.64 | 6,025,889,662 |
| 少数股东权益 | 221,873,823.74 | 230,057,380.64 | 262,396,586.58 | 266,211,801.37 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 6,110,322,156.91 | 6,128,653,230.88 | 6,307,899,942.22 | 6,292,101,463.37 |
| 负债和股东权益合计 | 6,829,941,182.42 | 6,933,422,004.03 | 7,240,838,105.7 | 7,386,599,894.2 |
| 公告日期 | 2024-10-31 | 2024-08-29 | 2024-04-30 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |